Latest news & insights
UK to introduce world-first regulatory framework for manufacture of innovative medicines at the point of patient care
The UK is the first country to establish a dedicated regulatory framework for manufacturing innovative medicines at or near the point of patient care
Director promotion for regulatory affairs professional Dr Eric Hardter
Boyds is delighted to announce the promotion of Eric Hardter to Director of Regulatory Affairs.
Dr Katherine Bowen promoted to Vice President of Regulatory Affairs
Boyds is delighted to announce the appointment of Dr Katherine Bowen to Vice President of Regulatory Affairs. Katherine joined Boyds in 2022 as Senior Director
Prof Alan Boyd awarded Fellowship of the British Pharmacological Society
Professor Alan Boyd, CEO and President of Boyds, has been awarded Fellowship of the British Pharmacological Society (BPS). The prestigious award recognises Alan’s standout contribution to pharmacology.
Boyds appoints regulatory affairs professional
Boyds is delighted to announce the appointment of Matt O’Connor who joins the company as Senior Manager, Regulatory Affairs. Matt joins Boyds following more than
Trio of shortlistings for Boyds in TOPRA Awards 2024
The Boyds team made the shortlist for three categories in the TOPRA Awards for Regulatory Excellence. The TOPRA Awards for Regulatory Excellence are the annual
Boyds announces four promotions
Boyds is pleased to announce the following promotions across the company.
Navigating the challenges of developing delivery devices for cell and gene therapy products in Europe
An article authored by Dr Patrick Ginty, Senior Director of Regulatory Affairs at Boyds, and Eamonn McGowran, Associate Director of Regulatory Affairs, has been published in Cell & Gene Therapy Insights’ August 2024 ‘Spotlight On’ innovation in cellular immunotherapy.
